Over-the-counter ibuprofen: How and why is it used?

International Journal of Pharmacy Practice

Volumn 8, Issue 2, 2000, Pages 121-127

  Sinclair, Hazel K ^a   Bond, Christine M ^a   Hannaford, Philip C ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; NON PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; DRUG CAPSULE; DRUG CONTRAINDICATION; DRUG SURVEILLANCE PROGRAM; FEMALE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; PHARMACIST; PRIORITY JOURNAL; QUESTIONNAIRE; TABLET; UNITED KINGDOM; WHEEZING;

EID: 0033931509     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.2000.tb00996.x     Document Type: Article

References (21)

1. Levin, LS. Self medication in Europe: some perspectives on the role of the pharmacist. In: Lund I, Dukes G, editors. The role and function of the pharmacist in Europe. Report of a WHO working group. Groningen: Styx Publications, 1988.
2. Herxheimer A. Self-medication industry is determined to expand. Lancet 1999;353:2136.
3. Blenkinsopp A, Bradley C. Patients, society, and the increase in self medication. BMJ 1996;312:629-32.
4. Thomas DHV, Noyce P. The interface between self medication and the NHS. BMJ 1996;312:688-91.
5. Bond CM, Bradley C. The interface between the community pharmacist and patients. BMJ 1996;312:758-60.
6. Bradley C, Blenkinsopp A. The future of self medication. BMJ 1996;312:835-7.
7. Sinclair HK, Bond CM, Hannaford PC. Pharmacovigilance of over the counter products based in community pharmacy: a feasible option? Pharmacoepidemiol Drug Saf 1999;8:479-91.
8. British National Formulary. Number 37. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 1999.
9. Blower AL, Brooks A, Fenn GC, Hill A, Pearce MY, Morant S, Bardhan KD. Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Aliment Pharmacol Ther 1997;11:283-91.
10. MacDonald TM, Morant SV, Robinson GC, Shield MJ, McGilchrist MM, Murray FE, McDevitt DG. Association of upper gastrointestinal toxicity of non-steroidal antiinflammatory drugs with continued exposure: cohort study. BMJ 1997;315:1333-7.
11. American Society of Health-System Pharmacists therapeutic position statement on the safe use of oral nonprescription analgesics. Am J Health-Syst Pharm 1999;56:1126-31.
12. Top five OTC brands. Pharm J 1999;262:610.
13. Moore N, Van Ganse E, Le Parc JM, Wall R, Schneid H, Farhan M, Verriere F, Pelen F. The PAIN Study: Paracetamol, Aspirin and Ibuprofen New Tolerability Study. Clin Drug Invest 1999;2:89-98.
14. Carstairs V, Morris R. Deprivation and Health in Scotland. Aberdeen: Aberdeen University Press 1991:305-17.
15. SPSS for Windows 7. Chicago, IL: SPSS Inc, 1996.
16. Rainsford KD, Roberts SC, Brown S. Ibuprofen and paracetamol: relative safety in non-prescription doses. J Pharm Pharmacol 1997;49:345-76.
17. Batty GM, Oborne CA, Swift CG, Jackson SHD. The use of over-the-counter medication by elderly medical in-patients. Postgrad Med J 1997;73:720-2.
18. Sheftell FD. Role and impact of over-the-counter medications in the management of headache. Neurol Clin 1997;15:187-98.
19. Asthmatics ignorant of OTC drug dangers. Chem Drug 1999; June 19:VIII.
20. Herxheimer A. Many NSAID users who bleed don't know when to stop. BMJ 1998;316:492.
21. Herxheimer A. Leaflets with NSAIDs do not warn users clearly - a UK survey. Pharm J 1999;262:559-61.